Enasidenib induces acute myeloid leukemia cell differentiation to promote clinical response. (2017)

First Author: Amatangelo MD

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1182/blood-2017-04-779447

PubMed Identifier: 28588019

Publication URI: http://europepmc.org/abstract/MED/28588019

Type: Journal Article/Review

Volume: 130

Parent Publication: Blood

Issue: 6

ISSN: 0006-4971